BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN
BEGIN:VTIMEZONE
TZID:Central Standard Time
BEGIN:STANDARD
DTSTART:20251102T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11
TZNAME:Central Standard Time
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250301T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3
TZNAME:Central Daylight Time
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:Dr. Podolanczuk is a nationally and internationally recognized
expert in interstitial lung disease. She received her undergraduate degree
in Neuroscience from Brown University. She earned her MD from NYU School
of Medicine. She completed residency in Internal Medicine and fellowship i
n Pulmonary and Critical Care Medicine at Columbia University. She receive
d additional training in advanced pulmonary diseases at Columbia Universit
y. She also earned a Masters of Science in Patient-Oriented Research from
Columbia’s Mailman School of Public Health\, with a focus on epidemiology
and biostatistics.\n \;\nDr. Podolanczuk is an NIH-funded investigator
studying novel risk factors for pulmonary fibrosis in humans. Her researc
h program focuses on understanding early or subclinical interstitial lung
disease\, characterizing imaging and blood biomarkers of pulmonary fibrosi
s\, the role of environmental exposures\, and the connection between cardi
ovascular disease and pulmonary fibrosis. She is also a site investigator
for several multi-center clinical trials of new therapies for pulmonary fi
brosis.\n\nSPONSORED WITH THE GENEROUS SUPPORT OF\n\n \n \n
\n \n \n \n \n
\n \n \n\n\n \;
DTEND:20220914T180000Z
DTSTAMP:20260518T063822Z
DTSTART:20220914T170000Z
LOCATION:
SEQUENCE:0
SUMMARY:Progressive Pulmonary Fibrosis: What Patients Need to Know
UID:RFCALITEM639146651029761472
X-ALT-DESC;FMTTYPE=text/html:Dr. Podolanczuk is a nationally and inter
nationally recognized expert in interstitial lung disease. She received he
r undergraduate degree in Neuroscience from Brown University. She earned h
er MD from NYU School of Medicine. She completed residency in Internal Med
icine and fellowship in Pulmonary and Critical Care Medicine at Columbia U
niversity. She received additional training in advanced pulmonary diseases
at Columbia University. She also earned a Masters of Science in Patient-O
riented Research from Columbia’s Mailman School of Public Health\, with a
focus on epidemiology and biostatistics.
\n \;
\nD
r. Podolanczuk is an NIH-funded investigator studying novel risk factors f
or pulmonary fibrosis in humans. Her research program focuses on understan
ding early or subclinical interstitial lung disease\, characterizing imagi
ng and blood biomarkers of pulmonary fibrosis\, the role of environmental
exposures\, and the connection between cardiovascular disease and pulmonar
y fibrosis. She is also a site investigator for several multi-center clini
cal trials of new therapies for pulmonary fibrosis.
\n
\n
SPONSOR
ED WITH THE GENEROUS SUPPORT OF
\n
\n
\;
END:VEVENT
END:VCALENDAR
